Elijah Dottery, a young sickle cell patient from Saginaw, was recently chosen as Detroit Lions' player Aidan Hutchinson's ...
2don MSN
Beam Therapeutics Inc. (BEAM) reports updated data from BEACON Phase 1/2 Trial of Ristoglogene
Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2, 2025, ...
Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...
AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...
SAGINAW, Mich. (WNEM) - At just 10 years old, Elijah Dottery has already faced more challenges than most people will in a ...
Besides, these items, which are always in high demand at the hospital, according to officials, would henceforth augment their ...
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red blood cell (RBC) sickling and hemolytic ...
Standard treatments can significantly lower the risk of stroke in children with sickle cell anemia, according to a review of ...
Studies show a partial-match bone marrow transplant is rewriting the future for sickle cell patients, with survival rates ...
The answer is "it should be," says columnist. That way, sickle cell patients could receive the support that they need.
For the first time, scientists say new therapies have the power to cure sickle cell disease. The disease is a devastating, ...
PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results